- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06955442
Racial Disparities in Acute Stroke (ERDAS)
Analysis of Ethnic and Racial Disparities in Access to Acute Stroke Care in Italy: A Multicentric, Prospective Cohort Study
Ischemic stroke is one of the leading causes of mortality and disability worldwide. Although the prevalence of stroke is high globally, not all ethnic and racial groups are affected in the same way, leading to the classification of stroke as an inequitable disease.
First of all, ethnic and racial background influences the pathogenesis of stroke, as numerous risk factors-both modifiable and non-modifiable-are more prevalent in Black and Hispanic populations compared to Asian ones. As a direct consequence, the incidence of stroke is higher in Black and Hispanic individuals than in White individuals. Unfortunately, despite this, access to revascularization treatments is not always guaranteed for ethnic and racial minorities, although in recent years, this inequality in access to care appears to be decreasing.
Moreover, stroke prognosis also seems to differ based on race/ethnicity, with mortality being higher among Black individuals compared to White individuals, although this trend tends to decrease with advancing age. On the other hand, although cerebral hemorrhage is more prevalent in Black and Asian populations than in White populations, it tends to have a better prognosis in these minority groups.
It must be considered, however, that the vast majority of studies on this topic have been conducted in the United States, where the ethnic and racial composition of the population is very different from that of Italy and Europe. In these latter contexts, studies investigating the impact of race and/or ethnicity on the clinical characteristics, management, and prognosis of ischemic stroke are lacking. Furthermore, differences in healthcare system organization may play a significant role in limiting access to timely and appropriate medical care for acute stroke based on race and/or ethnicity.
Italy is a country where, similarly to other European nations, the last few decades have seen a significant increase in immigration rates, particularly from Eastern Europe. Today, foreigners account for approximately 9% of the total population. Nevertheless, in Italy, systemic racism toward ethnic and racial minorities remains a significant issue, as evidenced by large disparities in educational attainment, socioeconomic status, and housing conditions between Italian citizens and foreign residents.
Although the universal national healthcare system in Italy should ensure equal access to care and emergency treatment for all, regardless of ethnic and racial background, there are no studies investigating this topic. A recent scoping review highlighted how individual racism plays a primary role in generating health inequalities, whereas there is very limited evidence focused on the analysis of structural and institutional racism in the Italian and European context.
As a consequence, this study aims to prospectively investigate the presence and the extent of racial and ethnic disparities in access to stroke care and treatment across several Italian comprehensive stroke centers.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Bologna, Italy, 40124
- Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna - UO Neurologia OM e Rete Stroke Metropolitana (SC)
-
Bologna, Italy, 40124
- UOS Neurologia-AOU, IRCCS Istituto delle scienze Neurologiche
-
Crema, Italy, 26013
- UOC Neurologia, ASST Crema
-
Frosinone, Italy, 03100
- UOC Neurologia - Ospedale Spaziani
-
Genova, Italy, 16132
- IRCCS Ospedale Policlinico San Martino
-
Lecce, Italy, 73100
- Ospedale Vito Fazzi
-
Naples, Italy, 80131
- Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
-
Pavia, Italy, 27100
- Fondazione IRCCS Policlinico San Matteo
-
Pavia, Italy, 27100
- IRCCS Fondazione Istituto Neurologico C. Mondino
-
Pozzilli, Italy, 86077
- IRCCS Istituto Neurologico Mediterraneo Neuromed
-
Roma, Italy, 00133
- Policlinico Tor Vergata
-
Rome, Italy, 00161
- Policlinico Umberto I
-
Rome, Italy, 00168
- Fondazione Policlinico Universitario A. Gemelli IRCCS
-
Rozzano, Italy, 20089
- Humanitas Research Hospital IRCCS
-
Viterbo, Italy, 01100
- UOC Neurologia Belcolle - Ospedale Belcolle
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults (≥18 years old);
- Admission to the Emergency Department of the participating center with a diagnosis of ischemic stroke, as defined by the International Classification of Diseases, 9th Revision (ICD-9) codes;
- Signed informed consent provided by the patient or, in cases of impaired decision-making capacity, by their legal guardian/representative.
Exclusion Criteria:
- Discharge diagnosis other than ischemic stroke;
- Refusal to participate in the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients presenting to the ED for acute ischemic stroke
Patients will be divided into several subgroups based on their racial/ethnic belonging (Asian/Hispanic/Black/White/Others).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Racial/ethnic disparities in the access to revascularization treatments
Time Frame: Baseline
|
Comparison of the likelihood of undergoing revascularization treatments among patients from different racial and/or ethnic groups.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Racial/ethnic disparities in onset to door times
Time Frame: Baseline
|
Comparison of Onset-to-Door Time among patients from different racial and/or ethnic groups.
|
Baseline
|
|
Racial/ethnic disparities in door to needle times
Time Frame: From the time of ED admission at baseline to start of intravenous thrombolysis
|
Comparison of differences in Door-to-Needle Time (DTN) between patients from different racial and/or ethnic groups.
|
From the time of ED admission at baseline to start of intravenous thrombolysis
|
|
Racial/ethnic disparities in door to groin times
Time Frame: From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy
|
Comparison of differences in Door-to-Groin Time (DTG) between patients from different racial and/or ethnic groups.
|
From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy
|
|
Racial/ethnic differences in mode of emergency department arrival
Time Frame: Baseline
|
Comparison of ED arrival modes (walk-in vs emergency medical services) among patients from different racial and/or ethnic groups.
|
Baseline
|
|
Racial/ethnic differences in the prevalence of cardiovascular risk factors
Time Frame: Baseline
|
Comparison of the prevalence of cerebrovascular risk factors among patients from different racial and/or ethnic groups.
|
Baseline
|
|
Racial/ethnic differences in onset symptoms of stroke
Time Frame: Baseline
|
Comparison of stroke clinical presentation patterns among patients from different racial and/or ethnic groups.
|
Baseline
|
|
Racial/ethnic differences in stroke pathogenesis
Time Frame: From enrollment to hospital discharge, up to 90-days from baseline
|
Comparison of stroke etiologies, classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria, among patients from different racial and/or ethnic groups.
|
From enrollment to hospital discharge, up to 90-days from baseline
|
|
Racial/ethnic differences stroke outcome at discharge
Time Frame: From enrollment to hospital discharge, up to 90-days from baseline
|
Comparison of discharge modified Rankin Scale (mRS) scores among patients from different racial and/or ethnic groups.
|
From enrollment to hospital discharge, up to 90-days from baseline
|
|
Racial/ethnic differences in 3-month stroke outcome
Time Frame: From enrollment to the 3-month follow-up visit
|
Comparison of 3-month modified Rankin Scale (mRS) scores after acute ischemic stroke among patients from different racial and/or ethnic groups.
|
From enrollment to the 3-month follow-up visit
|
Collaborators and Investigators
Investigators
- Principal Investigator: Giovanni Frisullo, Fondazione Policlinico Universitario A. Gemelli, IRCCS
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7467
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingStroke | Stroke Gait Rehabilitation | Stroke Ischemic | Balance Deficits | Stroke (CVA) or Transient Ischemic AttackUnited States
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan